Skip to main content

Table 1 Clinical data of patients with or without ALI after CPB surgery

From: Association of apolipoprotein A1 -75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery

Variable

ALI

Without ALI

P

Total no.

300

300

 

Age (years)

59.1 ± 10.6

56.8 ± 9.4

0.005

Gender (Male/Female)

205/95

201/99

0.73

ASA

2.77 ± 0.71

2.67 ± 0.65

0.07

NYHA

2.69 ± 0.67

2.57 ± 0.55

0.02

LVEF (%)

59.68 ± 7.94

60.68 ± 8.04

0.13

Previous cardiac surgery (%)

45 (15.0)

30 (10.0)

0.07

Hypertension (%)

75 (25.0)

70 (23.3)

0.63

Diabetes mellitus (%)

26 (8.7)

24 (8.0)

0.77

Obesity (%)

70 (23.3)

48 (16.0)

0.03

Peripheral vascular disease (%)

43 (14.3)

26 (8.7)

0.03

Transfusion (mL)

694.3 ± 103.7

687.3 ± 99.8

0.40

Duration of operation (min)

231.7 ± 90.1

210.5 ± 82.3

0.003

Duration of CPB (min)

106.7 ± 43.7

99.5 ± 41.5

0.04

Duration of cross-clamp (min)

62.1 ± 32.4

60.7 ± 31.9

0.59

Surgery

   

  Valvular surgery (%)

176 (58.7)

183 (61.0)

0.56

  CABG surgery (%)

99 (33.0)

102 (34.0)

0.80

  Aortic surgery (%)

25 (8.3)

15 (5.0)

0.11

  1. ALI, Acute lung injury; CPB, Cardiopulmonary bypass; ASA, American Society of Anesthesiology; NYHA, New York Heart Association; LVEF, Left ventricular ejection fraction; CABG, Coronary artery bypass graft.